1) Klareskog L, Padyukov L, Rönnelid J, et al : Genes, environment and immunity in the development of rheumatoid arthritis. Curr Opin Immunol 18:650-655,2006
2) Karlson EW, Lee IM, Cook NR, et al : A retrospective cohort study of cigarette smoking and risk of rheumatoid arthritis in female health professionals. Arthritis Rheum 42:910-917,1999
3) Sugiyama D, Nishimura K, Tamaki K, et al : Impact of smoking as a risk factor for developing rheumatoid arthritis : a meta-analysis of observational studies. Ann Rheum Dis 69:70-81,2010
4) de Vries RR, van der Woude D, Houwing JJ, et al : Genetics of ACPA-positive rheumatoid arthritis : the beginning of the end? Ann Rheum Dis 70(Suppl):i51-i54,2011
5) Lee DM, Phillips R, Hagan EM, et al : Quantifying anti-cyclic citrullinated peptide titres : clinical utility and association with tobacco exposure in patients with rheumatoid arthritis. Ann Rheum Dis 68:201-208,2009
6) Klareskog L, Stolt P, Lundburg K, et al : A new model for etiology of rheumatoid arthritis. smoking may trigger HLA-DR (shred epitope)-restricted immune reactions in aoutoantigens modified by citrullication. Arthritis Rheum 54:38-46,2006
7) Pedersen M, Jacobsen S, Garred P, et al : Strong combined gene-environment effects in anti-cyclic citrullinated peptide-positive rheumatoid arthritis : a nationwide case-control study in Denmark. Arthritis Rheum 56:1446-1453,2007
8) Stolt P, Yahya A, Bengtsson C, et al : Silica exposure among male current smokers is associated with a high risk of developing ACPA-positive rheumatoid arthritis. Ann Rheum Dis 69:1072-1076,2010
9) 熊谷俊一:関節リウマチの早期診断と治療.平成22年度日本内科学会生涯教育講演会(Aセッション).日内会誌 100:730-735,2011
10) Klareskog L, Rönnelid J, Lundberg K, et al : Immunity to citrullinated proteins in rheumatoid arthritis. Annu Rev Immunol 26:651-75,2008
11) EI-Gabalawy H : The preclinical stages of RA : lessons from human studies and animal models. Best Pract Res Clin Rheumatol 23:49-58,2009